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 AbstrAct
In learning genetics, many students misunderstand and misinterpret what 
“dominance” means. Understanding is easier if students realize that dominance 
is not a mechanism, but rather a consequence of underlying cellular processes. 
For example, metabolic pathways are often little affected by changes in enzyme 
concentration. This means that enzyme-producing alleles usually show com-
plete dominance. For genes producing nonenzymatic proteins such as collagen 
or hemoglobin, the amount of product matters, and dominance relationships 
are more complicated. Furthermore, with hemoglobin, dominance can change 
depending on what aspect of the phenotype is being studied and on the environ-
mental conditions. X-linked genes are a special case, whether enzymatic or not. 
Because of X-chromosome inactivation, only one X-linked allele can be active in 
a cell, which means that the concept of dominance cannot be applied at the cel-
lular level. Instead, a type of dominance is demonstrated at the individual level; 
but even so, dominant traits may fail to be expressed, and recessive traits can be 
expressed. Teaching not only what is happening but why it’s happening will give 
students a deeper understanding, not only of dominance relationships, but of the 
underlying cellular processes as well.
Key Words: Dominance relationships; enzymes and structural proteins; 
X-chromosome genes and dominance; instruction.
Dominance relationships are “commonly misunderstood and mis­
interpreted” by students learning genetics. Some believe that “dom­
inance … depends on some mysterious, unknown and perhaps 
unknowable force” (Heim, 1991, p. 94). Others say that it is “based 
on power, strength and value,” which leads to the misconceptions that 
dominant alleles dominate recessive alleles or that dominant alleles will 
naturally become more frequent in a popula­
tion (Allchin, 2000, p. 633; for other examples 
of student misunderstandings of dominance, 
see Redfield, 2012; Smith, 2014a, b). 
On the contrary, dominance is not a force or 
a power. Dominance is not a mechanism; rather, 
dominance relationships are a result. They are 
consequences of how gene products function 
in a cell. Understanding goes both ways – 
understanding dominance relationships helps 
students understand cellular processes, and understanding  cellular 
processes helps students understand dominance relationships. 
Dominance pertains only to the phenotype (observable char­
acteristics) of a heterozygote (Table 1). It describes the relationship 
between allelic products, between products of different versions of 
the same gene in a heterozygous individual. Alleles by themselves 
do not have dominance; dominance/recessiveness is not built into 
our DNA. Referring to an allele by itself as dominant or recessive is 
misleading and can hamper understanding. In addition, dominance 
relationships apply only to a single gene; one gene cannot be domi­
nant to a different gene, even though it may alter or even suppress 
the function of that gene.
I will discuss three types of dominance relationships here: 
(1) complete dominance (or being haplo­sufficient); (2) incomplete 
dominance (or being haplo­insufficient); and (3) the interesting and 
unusual case of X­chromosome genes. Table 2 explains the mecha­
nisms underlying complete and incomplete dominance. Although 
the following examples are restricted to humans, the same principles 
apply to all diploids, with the exception of X­linked genes in organ­
isms such as Drosophila, in which X­chromosome inactivation does 
not occur.
Genes That Code for an Enzyme: J JJ
Complete Dominance
We often study traits in which different genotypes produce obvious 
and noticeably different phenotypes, as with albinism, Tay Sachs 
 disease, phenylketonuria, and many others. 
For these, there is complete dominance because 
a single functional allele is sufficient to pro­
duce the nondisease phenotype (Table 2). This 
relationship is common in genes that code 
for enzymes, as in the three examples above 
(Lanza & Cress, 2001).
Students could be asked what this tells 
us about enzymes. First, it emphasizes that 
enzymes, by their nature, are not used up 
volume: 76
Issue: 9
year: 2014
Month: November/December
Running Footer: Genetic Dominance
 576 The american biology Teacher volume 76, no. 9, november/December 2014
Dominance relationships 
are “commonly 
misunderstood and 
misinterpreted” by 
students learning genetics.
   
F e a t u r e  a r t i c l e   Genetic Dominance & Cellular 
Processes
R o b e R t  D.  S e a g e R
The American Biology Teacher, vol. 76, no. 9, pages 576–581. iSSn 0002-7685, electronic iSSn 1938-4211. ©2014 by national association of biology Teachers. all rights reserved.  
request permission to photocopy or reproduce article content at the university of california Press’s rights and Permissions Web site at www.ucpressjournals.com/reprintinfo.asp. 
Doi: 10.1525/abt.2014.76.9.2
during a reaction. From this, it follows that in many cases, not 
a lot of enzyme is necessary for proper functioning, given that 
decreasing the amount of available enzyme by half has no effect. 
An overall conclusion is that enzymatic (metabolic) pathways in 
general are not particularly sensitive to changes in enzyme con­
centration. But what about proteins that are not enzymes and that 
are needed in large quantities, such as collagen and hemoglobin 
(Wilkie, 1994)? 
Genes That Do Not Code for an Enzyme: J JJ
When the Amount Matters
Type I Collagen
There are many collagen genes and many different collagen proteins. 
Collagens hold our bodies together (“collagen” means “glue pro­
ducing”); for example, collagens are essential components of bones 
and tendons. A critical collagen is Type I, the major component of 
connective tissue and the most abundant protein found in humans 
(Prockop & Kivirikko, 1995). 
Collagen is also the largest, most  complex 
macromolecule found in humans. The Type 
I collagen genes are correspondingly large, 
and they frequently mutate as a consequence, 
leading to >300 known  connective­tissue 
disorders in humans (Di Lullo et al., 2002). 
A single Type I collagen disorder, osteogen­
esis imperfecta (see below), is associated 
with >800 independent mutations (Marini 
et al., 2007). What is the effect of these 
mutations?
Type I collagen is a structural protein 
that helps support the body, just as beams 
and columns provide structural support for 
a building. (Enzymes, by contrast, are analo­
gous to building tools, like hammers and saws, 
which are reused many times.) What would 
happen if there were no structural support at 
all? There would be no building, and no body. 
Homozygotes that lack any functional Type I 
collagen do not survive. Heterozygotes pro­
duce about half of the structurally sound col­
umns and beams the building (body) needs 
(see Table 2); the other half is either missing 
or defective (the mutated Type I collagen 
allele either makes no product at all or makes 
a defective one). Students should expect dire 
consequences in this case.
What does this predict about dominance 
relationships, about the phenotype of the 
hetero zygote? The amount of functional pro­
tein matters; a Type I collagen heterozygote 
should be affected. The fragile­bone disorder 
 osteogenesis imperfecta Type I is an example 
of this; the body is unsound and may even 
collapse – some Type I collagen mutations 
are lethal (Marini et al., 2007). For further 
information on Type I collagen and human 
genetics in general, see Online Mendelian Inheritance in Man 
(http://www.omim.org).
Hemoglobins: An Overview
Hemoglobin consists of two different proteins and is thus the product 
of two different genes; in adults, these are the hemoglobin α and 
hemoglobin β genes. Adult hemoglobin (α
2
β
2
) consists of two copies 
of each protein. Three other functional hemoglobin genes in humans, 
γ, δ and ε, are variants of the β gene – α
2
ε
2
 appears in the embryo, 
α
2
γ
2
 in the fetus, and α
2
δ
2
 comprises a small portion of adult hemo­
globin (Barton et al., 2007, and accompanying website).
A good question for students is “Why are there so many hemo­
globins?” More precisely, “What are the differences among the dif­
ferent hemoglobins, and are these differences appropriate for their 
different developmental environments?” For example, α
2
γ
2
 (fetal 
hemoglobin) has a slightly higher affinity for oxygen than the adult 
hemoglobin (α
2
β
2
) that later replaces it. How is this difference tied to 
the different oxygen needs of the fetus versus the adult? 
Fetal hemoglobin’s higher affinity for oxygen helps the fetus 
by making oxygen transport across the placenta more efficient 
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Table 1. Genes and alleles. The terms gene and allele are often used 
incorrectly. For example, there is no cystic fibrosis gene; instead, 
there is a gene that codes for a protein that regulates sodium and 
chloride transport across epithelial cell membranes. An individual 
with two altered or nonfunctional versions (alleles) of this gene has 
cystic fibrosis.
Gene The unit of heredity; all genes discussed here code 
for a polypeptide/protein.
Alleles Different versions of the same gene; genes have 
many alleles. 
Homozygote/homozygous The two alleles are the same (homo).
Heterozygote/heterozygous The two alleles are different (hetero).
Table 2. Gene action and dominance. “A1” and “A2” are used for the 
alleles because using “A” and “a” is appropriate only when there is 
complete dominance.
Alleles A1 Produces a functional product/protein
A2 Produces a nonfunctional product or no 
product at all
Genotypes A1 A1 homozygote Produces functional product
A1 A2 heterozygote Produces about half as much functional 
product as A1 A1
A2 A2 homozygote No functional product (or no product at all) 
produced
Notes: Dominance pertains to the phenotype of the heterozygote. Complete (or full) dominance 
describes the situation when the heterozygote and the A1 A1 homozygote have the same phenotype. 
This happens if “about half as much functional product” is enough for full functioning. Since only one 
functional allele (A1) is sufficient for full functioning, this can also be called haplo-sufficient (= “one 
allele is sufficient”). If “about half as much functional product” is not enough for full functioning, the 
heterozygote will have a different phenotype than either homozygote. This is incomplete dominance; 
the functional allele (A1) is haplo-insufficient.
(Elmissbah & Abdalla, 2012). Outside of the uterus, this can cause 
problems. If the amount of oxygen in the body is low (hypoxia), 
fetal hemoglobin is harmful. Because it holds onto its oxygen more 
strongly than adult hemoglobin, fetal hemoglobin would release less 
oxygen to the body to counter the hypoxia.
 A further, seemingly simple question: Can any vertebrate survive 
without hemoglobin? All vertebrates require oxygen, and all verte­
brates started out with hemoglobin. Are there conditions in which 
hemoglobin actually became harmful and was selected against?
Surprisingly, yes: There is a group of fish living in very cold 
Antarctic waters. Under these conditions, hemoglobin would 
make the blood too viscous (too thick) and thus extremely hard to 
 circulate. A good analogy is how slowly syrup kept in the refrig­
erator (the “Antarctic”) pours, compared with syrup kept at room 
temperature. Indeed, it was selection against hemoglobin and for 
reduced blood viscosity that allowed these fish to expand into and 
inhabit Antarctic waters in the first place (di Prisco et al., 2007 [more 
 technical]; Carroll, 2009 [less technical]). In every other case, as with 
Type I collagen, survival is impossible without hemoglobin; having 
no hemoglobin at all is lethal.
β hemoglobin & sickle cell anemia
The β hemoglobin variant associated with sickle cell anemia (Medzhitov 
et al., 2012) is well known and displays  complex  dominance 
 relationships. The sickle cell allele codes for an altered, less func­
tional β hemoglobin (“S”), and as with Type I collagen, the amount of 
fully functional β hemoglobin (“A”) matters (Table 3). 
Homozygosity for the altered β hemoglobin (SS; sickle cell 
anemia) causes severe health risks and is often lethal: in sub­
Saharan Africa, an estimated 50–80% of individuals with sickle 
cell anemia die before adulthood. The World Health Organization 
estimates that 70% of these deaths could be avoided by the use of 
simple, cost­effective intervention strategies available in countries 
such as the United States, where up to 94% of individuals with 
sickle cell anemia survive to at least 18 years of age (Makani et al., 
2011).
Students can be challenged to explain why S hemoglobin is such 
a problem. A good way to start is to compare the chemical composi­
tion of A versus S hemoglobin. As is well documented, there is only 
a single amino acid difference: Glutamic acid in the fully functional 
A molecule has been replaced by valine in the S variant. Why is this 
change so significant? 
First, the relevant amino acid is exposed on the surface of the 
 hemoglobin molecule. This means that it can interact both with the 
aqueous cellular environment and with other hemoglobin molecules. 
Second, the glutamic acid side group in the nonmutated A hemo­
globin ends in carboxylic acid (–COOH). Since acids are soluble in 
water, A type hemoglobin is water soluble or hydrophilic (“water 
loving”). 
By contrast, valine, its replacement in S hemoglobin, ends with 
non­water­soluble methyl groups (–CH
3
). Thus, S hemoglobin is less 
water­soluble or hydrophobic (“water hating”) and, therefore, harder 
to move around within the cell than A hemoglobin (Mosby, 2009).
This amino acid difference is not much of a problem when 
S hemoglobin is carrying oxygen. However, when the oxygen is 
released, both S and A hemoglobin molecules change shape, exposing 
a formerly hidden and hydrophobic part of the molecule. 
This is not a problem with the hydrophilic A hemoglobin, but 
it is with S hemoglobin. The hydrophobic valine of S hemoglobin is 
attracted to the newly exposed hydrophobic part of adjacent hemo­
globins. This continues until insoluble, and unusable, clumps of 
hemoglobin are formed within the red blood cells (RBCs). An excel­
lent illustration of this is on a website maintained by the University 
of Wisconsin (2012).
The consequence for SS homozygous individuals is sickle cell 
anemia, in which the oxygen­carrying capacity of RBCs is greatly 
reduced. Making things worse, S hemoglobin releases its oxygen 
more easily, and thus changes shape more easily, than A hemo­
globin (Riggs & Wells, 1961). Therefore, in SS people, the clumping 
problem will happen fairly quickly. The RBCs become distorted and 
relatively inflexible, and some become sickle shaped. Students can 
be directed to an excellent website created by Harvard University 
(2002), which helps explain this situation.
The consequences are more complicated for heterozygous 
 individuals (AS – sickle cell trait). Questions of dominance pertain 
to the phenotype of the heterozygote (see Table 2). It is critical to 
remember, when studying dominance relationships, that phenotypes 
result from a combination of genetic and environmental influences. 
AS heterozygotes provide a good example of this. When oxygen levels 
are sufficient, a single functional allele (A) is enough to supply the 
body with adequate oxygen; A is dominant to S.
This situation reverses for AS heterozygotes when there is less 
oxygen in the air because of high altitude, a higher metabolic need 
for oxygen because of physical exertion, or both. In these cases, 
there is not enough fully functional A hemoglobin to supply the body 
with adequate oxygen, and S becomes dominant to A. The prob­
lems associated with the S allele occur as they do in SS homozygotes; 
hemoglobin is less likely to be fully oxygenated, hemoglobin aggre­
gates are more likely to form, and many of the red blood cells sickle. 
A heterozygous individual experiences symptoms similar to sickle 
cell anemia (see Table 3).
This environmentally altered phenotype is a serious public health 
issue. Sickle cell trait (AS) is often undiagnosed unless a problem 
occurs, and this has led to military recruits dying during basic training 
(Eckart et al., 2004) and athletes dying during 
intense workouts (Eichner, 2007). Recently 
the National Athletic Trainers’ Association 
issued a position statement on preventing 
sudden death in sports, including appro­
priate standards for working with athletes 
with sickle cell trait (Casa et al., 2012).
The harmful effects of high altitude and 
physical exertion were experienced by Ryan 
Clark, a defensive back with the Pittsburgh 
Steelers football team. Clark has the sickle 
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Table 3. “A” is fully functional β hemoglobin. This can be confusing; 
“A” has nothing to do with α hemoglobin. “S” is sickle cell β hemo-
globin.
Genotype Phenotype
AA No problems with hemoglobin (no sickle cell problems)
AS Sickle cell trait: sickle cell problems under oxygen stress, otherwise OK
SS Sickle cell anemia: severe sickle cell problems in all environments
cell trait (AS), and in 2007, he played foot­
ball at the high­altitude Mile High Stadium 
in Denver, Colorado. The consequences were 
devastating. Clark almost died and had to 
have his spleen and gallbladder removed 
(Quick, 2012).
Hemoglobin, sickle cell, & malaria
There is a further complication. The reason 
for the relatively high frequency of S, the 
sickle allele, is that AS heterozygotes have an 
increased resistance to malaria. In malarial 
environments (which typically occur at low 
altitudes), S is dominant to A for malarial resistance (the AS heterozy­
gote is more malarial resistant than the AA homozygote). By contrast, 
S is recessive to A for sickle cell anemia unless there is significant 
physical exertion (given that the altitudes are low; Table 4).
What about SS homozygotes? If one S allele offers protection 
against malaria, wouldn’t two of them be even better? The answer 
is paradoxical: A 5­year study in Tanzania found that individuals 
with sickle cell anemia (SCA) indeed had lower levels of the malarial 
parasite than individuals without SCA, but SCA individuals were at 
a higher risk for severe anemia and death than those without SCA 
(Makani et al., 2010).
The best explanation of this paradox is that individuals with SCA 
do have some protection from malarial infection (lower parasitemia). 
However, because of their generally weakened condition, they have a 
much lower tolerance for malaria itself. In addition, malaria itself can 
cause anemia, greatly worsening the anemia already present.
To summarize, the β hemoglobin sickle allele (S), when homozy­
gous, is both harmful and, in malarial regions, somewhat helpful, 
because it apparently confers some resistance to malaria. However, 
the benefits of this resistance are overshadowed by the greater 
 vulnerability of SS homozygotes to the effects of malaria. When 
paired with a functional β hemoglobin allele (AS), S is beneficial in 
malarial regions, neutral if malaria is absent, and harmful if the indi­
vidual is undergoing oxygen stress.
X-linked Genes: A Special CaseJ JJ
In mammals, both males and females have only one active ( functional) 
X chromosome per cell. Although this occurs no matter how many 
X chromosomes are present (e.g., in XXX or XXY individuals), the 
following discussion is restricted to XX females and XY males. If an 
XX female is genetically heterozygous, in each of her cells only one of 
her two X­linked alleles is expressed. The other X chromosome coils 
up and becomes inactive (i.e. becomes a Barr body).
This happens independently in each initial cell, which means 
that some cells will have one of the alleles inactivated and other 
cells will have the other allele inactivated. Heterozygous females 
thus have two different cell populations. This initial inactivation 
happens only once, and which allele is inactive is stably inher­
ited. All future cells will have the same active (expressed) and 
 inactive (not expressed) X chromosome (and X­linked allele) as the 
initial cell.
Remember that dominance relationships are a function of the 
phenotype of a heterozygote (see Table 2). X­linked heterozygotes do 
not exist at the cellular level because both alleles are not expressed; 
therefore, traditional dominance relationships for X­linked genes do 
not exist either.
Even though no single cell is functionally heterozygous, an XX 
female can be heterozygous as a whole, but with a crucial difference. 
In an autosomal (non­sex­chromosome) heterozygote, if one allele is 
defective, every cell will produce functional product. In an X­linked 
heterozygote, if one allele is defective and the other functional, the 
consequence of X­chromosome inactivation is that some cells will 
produce only the functional product, whereas other cells will  produce 
only a defective product or no product at all.
There is another important consideration. Human X­chromosome 
inactivation occurs very early in development, when the embryo has 
few cells (Lyon, 2002). In a heterozygote, which X chromosome/
allele is inactivated in any given cell is random, but random does 
not necessarily mean equal, especially when the sample size is small. 
Students can visualize this with sets of 20 coins, corresponding to 
X­chromosome inactivation at the 20­cell stage. Each coin represents 
a cell, and the two sides of the coin represent the different alleles – 
the coin is “heterozygous.” When flipped, only one allele (one side) 
is seen; the face­down side represents the inactivated allele in the 
Barr body.
Students could be asked how often they expect an equal number 
of heads and tails – this can help them understand probability. The 
different sets of coins will display different patterns, and – perhaps 
surprisingly – seldom will there be an equal number of heads and 
tails. The coins will be binomially distributed; using this distribution, 
it can be calculated that only 18% of the time will there be an equal 
division of coins/cells.
The consequences of this can be observed in Lesch­Nyhan 
 syndrome. Lesch­Nyhan is the result of a defective allele of an 
X­linked enzyme­producing gene involved in purine metabolism. 
Because males have only one X chromosome, affected males will show 
symptoms, the severity of which depends on the specific nature of 
the mutation. More than 300 different disease­associated mutations 
have been identified (Torres et al., 2013). The least affected individ­
uals build up uric acid, and the associated gout can be successfully 
treated. Lesch­Nyhan syndrome is the most severe  manifestation – 
which, in addition to the buildup of uric acid, involves poor muscle 
control, mental impairment, and self­mutilation. While the uric acid 
problem is amenable to treatment, the cause of the neurological 
problems is poorly understood, and effective treatments do not exist 
(Torres et al., 2012).
As far as females are concerned, recall that a single functional 
allele of an enzyme­producing gene is most often completely domi­
nant over a nonfunctional allele (see Table 1). Because males with a 
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Table 4. The effect of malaria on people with different β hemoglobin 
genotypes (this is an extension of Table 3).
Genotype Phenotype
AA No problems with hemoglobin (no sickle cell problems), no 
increased resistance to malaria
AS Sickle cell trait: sickle cell problems when oxygen levels are low, 
otherwise OK; increased resistance to malaria
SS Sickle cell anemia: severe sickle cells problems in all environments; 
probably some resistance to malarial infections but not to malaria 
itself
single functional allele do not show symptoms, it might be expected 
that the same is true for females – while homozygous females should 
be affected, heterozygous females with their single functional allele 
should not be.
But they often are. Because the gene is X­linked, some cells will 
produce functional enzyme and others will not. Remind students of 
the skewed ratios frequently produced when 20 coins are flipped; 
if the ratio is skewed toward cells that do not produce functional 
enzyme, heterozygous females can be affected.
A particularly instructive case involves identical twin (monozy­
gotic) females, one of whom is clinically normal while the other has 
Lesch­Nyhan. The twins are identical in their DNA and identical 
in their genotypes – both are heterozygous for the same mutation 
(De Gregorio et al., 2005), so something else must be happening. 
Students with a good understanding of the material should be 
able to explain this finding. X­chromosome inactivation, even in 
genetically identical twins, is different in each of them because it is 
random. The affected twin had a skewed pattern of inactivation in 
which the chromosome carrying the functional allele was preferen­
tially inactivated; the unaffected twin had the opposite.
What about a nonenzymatic X­linked structural protein such as 
dystrophin, the lack of which causes muscular dystrophy? Dystrophin 
is part of the cell membranes of striated muscle fibers (Campbell & 
Kahl, 1989). It helps link muscle cells to the extracellular matrix, 
thereby helping maintain muscle integrity (Ibraghimov­Beskrovnaya 
et al., 1992). Unlike Type I collagen, in which the amount of product 
matters, a single functional allele produces enough dystrophin for full 
functioning, as shown by males who have a single functional allele 
but not muscular dystrophy.
Heterozygous females with some degree of muscular dystro phy 
are relatively common. Dubowitz in 1960 described ~40 such 
heterozygous females (by contrast, only a few heterozygous females 
have been identified with Lesch­Nyhan syndrome). As with Lesch­
Nyhan, in a pair of identical (monozygotic) twin girls, one twin had 
muscular dystrophy whereas the other did not (Richards et al., 1990). 
Many, but not all, of the muscle fibers in the twin with muscular dys­
trophy lacked dystrophin.
This illustrates another complication when considering females 
heterozygous for X­linked genes. During differentiation, different cell 
lineages lead to different structures. When X­chromosome inactiva­
tion occurs, not only can the overall ratio be skewed between cells 
expressing and cells not expressing the functional allele, but there can 
be different ratios in different parts of the body. For example, if most of 
the cells destined to become muscle fibers have a highly skewed ratio, 
with an even greater frequency of cells unable to make dystrophin, the 
muscular dystrophy symptoms will be even more severe.
This can also be illustrated with sets of 20 coins. Recall that the 
two sides of the coin represent the two different alleles, and when 
the coin is flipped, only one allele (one side) is seen; the face­down 
side represents the Barr body. Now (without looking) separate out 
five or six of these as muscle progenitor cells and look at the ratio; 
it may be the same as the overall ratio, but it also might be skewed 
toward more or fewer functional alleles. 
ConclusionsJ JJ
Biology (and science in general) can be mysterious (and boring) if 
students do not adequately understand the mechanisms underlying 
what they are studying. As teachers, we need to go beyond what is 
happening and teach why it’s happening. Unfortunately, biology can 
be taught as a “what subject” – as a memorization of facts without 
appropriate context. 
It is important to remember that concepts come first and terms 
later; terms enable us to talk about concepts, but they are secondary to 
understanding the concepts themselves. For example, a student who 
can diagram cell division but cannot name the different stages knows 
most of what is necessary for a good understanding of cell division. 
A student who has memorized the names of the stages but cannot 
draw cell division knows nothing of worth about the process.
Such is the case with dominance relationships – they can seem 
like magic (Heim, 1991). Understanding the why of dominance 
requires understanding the underlying genetic/cellular processes, 
such as the distinction between enzymes and structural proteins and 
the effects of X­chromosome inactivation. Students will then under­
stand that dominance relationships are the consequence of cellular 
processes and, as such, are themselves understandable.
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